As of January 1, 2022, CMA Joule resources were moved to a new entity within the CMA group of companies—CMA Impact Inc. Clinical information and learning products continue to use the CMA Joule brand and the CMAJ group of publications remains unchanged. CMA members and the medical community will continue to benefit from clinical resources, leadership training under the CMA Joule brand, and evidence-based knowledge from the CMAJ Group.
CMA Impact Inc. is a wholly owned subsidiary of the CMA. The CMA Impact Inc. board is responsible for overseeing its business and operations in alignment to the CMA’s strategy. The CMA Impact Inc. board members are Dr. Guruswamy Sridhar (Chair), Dr. Celina White, Dr. David Cram, Anne Marie O'Donovan and Tim Smith.